ICAM-l-Antisense-Therapie: Ein neues Behandlungskonzept beim M. Crohn? Plazebokontrollierte Studie einer ICAM-l-Antisense-Oligonukleotidtherapie beim M. Crohn.

Translated title of the contribution: ICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease

M. E. Martignoni, H. Friess

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Translated title of the contributionICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease
Original languageGerman
Pages (from-to)313-315
Number of pages3
JournalZeitschrift fur Gastroenterologie
Volume37
Issue number4
StatePublished - Apr 1999
Externally publishedYes

Cite this